Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Opinion
  • Published:

Preventing CVD in resource-poor areas: perspectives from the 'real-world'

Abstract

An evolving epidemic of cardiovascular disease (CVD) is having a profound effect on the health of vulnerable populations in low-to-middle income countries with limited resources. Despite some encouraging signs (particularly initiatives from the WHO), global and regional apathy towards noncommunicable forms of CVD adds to the complexity of issues to consider when establishing cost-effective prevention programs. We present our perspective on overcoming the myriad of barriers to providing cost-effective measures for CVD prevention in a resource-poor environment through the 'prism' of our experiences in establishing the Heart of Soweto Study in South Africa.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. World Health Organization. The global burden of disease: 2004 update. World Health Organization [online], (2008).

  2. Fox, C. S., Evans, J. C., Larson, M. G., Kannel, W. B. & Levy, D. Temporal trends in coronary heart disease mortality and sudden cardiac death from 1950 to 1999: the Framingham Heart Study. Circulation 110, 522–527 (2004).

    Article  Google Scholar 

  3. Stewart, S. et al. Trends in hospitalization for heart failure in Scotland, 1990–1996. An epidemic that has reached its peak? Eur. Heart J. 22, 209–217 (2001).

    Article  CAS  Google Scholar 

  4. Jhund, P. S. et al. Long-term trends in first hospitalization for heart failure and subsequent survival between 1986 and 2003: a population study of 5.1 million people. Circulation 119, 515–523 (2009).

    Article  Google Scholar 

  5. Abegunde, D. O., Mathers, C. D., Adam, T., Ortegon, M. & Strong, K. The burden and costs of chronic diseases in low-income and middle-income countries. Lancet 370, 1929–1938 (2007).

    Article  Google Scholar 

  6. Yusuf, S., Reddy, S., Ounpuu, S. & Anand, S. Global burden of cardiovascular diseases: Part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies. Circulation 104, 2855–2864 (2001).

    Article  CAS  Google Scholar 

  7. World Health Organization. 2008–2013 action plan for the global strategy for the prevention and control of noncommunicable diseases. World Health Organization [online], (2008).

  8. Stewart, S. et al. Mapping the emergence of heart disease in a black, urban population in Africa: the Heart of Soweto Study. Int. J. Cardiol. 108, 101–108 (2006).

    Article  Google Scholar 

  9. Tibazarwa, K. et al. A time bomb of cardiovascular risk factors in South Africa: results from the Heart of Soweto Study “Heart Awareness Days”. Int. J. Cardiol. 132, 233–239 (2009).

    Article  Google Scholar 

  10. Sliwa, K. et al. Spectrum of heart disease and risk factors in a black urban population in South Africa (the Heart of Soweto Study): a cohort study. Lancet 371, 915–922 (2008).

    Article  Google Scholar 

  11. Stewart, S. et al. Predominance of heart failure in the Heart of Soweto Study cohort: emerging challenges for urban African communities. Circulation 118, 2360–2367 (2008).

    Article  Google Scholar 

  12. Nissinen, A. et al. Community-based noncommunicable disease interventions: lessons from developed countries for developing ones. Bull. World Health Organ. 79, 963–970 (2001).

    CAS  PubMed  PubMed Central  Google Scholar 

  13. Yusuf, S., Reddy, S., Ounpuu, S. & Anand, S. Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation 104, 2746–2753 (2001).

    Article  CAS  Google Scholar 

  14. Gaziano, T. A. Reducing the growing burden of cardiovascular disease in the developing world. Health Aff. (Millwood) 26, 13–24 (2007).

    Article  Google Scholar 

  15. Leeder, S., Raymond, S., Greenburg, H., Liu, H. & Esson, K. A Race Against Time: The Challenge of Cardiovascular Disease in Developing Countries. (Trustees of Columbia University, New York, 2004).

    Google Scholar 

  16. Sridhar, D. & Batniji, R. Misfinancing global health: a case for transparency in disbursements and decision making. Lancet 372, 1185–1191 (2008).

    Article  Google Scholar 

  17. Howson, C. P. for the Committee on Research, Development, and Institutional Strengthening for Control of Cardiovascular Diseases in Developing Countries. Control of Cardiovascular Diseases in Developing Countries: Research, Development, and Institutional Strengthening (National Academies Press, Washington, 1998).

    Google Scholar 

  18. Jamison, D. et al. Disease Control Priorities in Developing Countries (Oxford University Press and the World Bank, New York, 2006).

    Google Scholar 

  19. Group, I. C. R. Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. Br. Med. J. 297, 319–328 (1988).

    Article  Google Scholar 

  20. Rose, G. The Strategy of Preventive Medicine (Oxford University Press, New York, 1992).

    Google Scholar 

  21. Jackson, R. Updated New Zealand cardiovascular disease risk-benefit prediction guide. Br. Med. J. 320, 709–710 (2000).

    Article  CAS  Google Scholar 

  22. Gaziano, T. A., Steyn, K., Cohen, D. J., Weinstein, M. C. & Opie, L. H. Cost-effectiveness analysis of hypertension guidelines in South Africa: absolute risk versus blood pressure level. Circulation 112, 3569–3576 (2005).

    Article  Google Scholar 

  23. Gaziano, T. A., Young, C. R., Fitzmaurice, G., Atwood, S. & Gaziano, J. M. Laboratory-based versus non-laboratory-based method for assessment of cardiovascular disease risk: the NHANES I Follow-up Study cohort. Lancet 371, 923–931 (2008).

    Article  Google Scholar 

  24. Wald, N. J. & Law, M. R. A strategy to reduce cardiovascular disease by more than 80%. Br. Med. J. 326, 1419 (2003).

    Article  CAS  Google Scholar 

  25. Gaziano, T. A., Opie, L. H. & Weinstein, M. C. Cardiovascular disease prevention with a multidrug regimen in the developing world: a cost-effectiveness analysis. Lancet 368, 679–686 (2006).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Simon Stewart.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stewart, S., Sliwa, K. Preventing CVD in resource-poor areas: perspectives from the 'real-world'. Nat Rev Cardiol 6, 489–492 (2009). https://doi.org/10.1038/nrcardio.2009.79

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrcardio.2009.79

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing